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SOME biological effects of chronic cigarette smoking (two
cigarettes for 2 h, daily for 4 months) in rats were evalu-
ated. During the smoking period, body weight of smo-
ker rats was always significantly lower than that of control
rats. Immediately after the last smoking session the car-
boxyhaemoglobin concentration in the blood was about
8.5% and the polymorphonuclear cells in the broncho-
alveolar fluid increased significantly. At the same time,
enzymatic analyses on the supernatants of bronchoalveolar
fluid revealed a significant increase of fl-glucuronidase in
the smoker group. Alveolar macrophages, collected 0, 8
and 24 h after the last smoking session, significantly in-
creased the generation of superoxide anion and, after
incubation for 24 h at 37C in a humidified atmosphere,
released significantly high amounts ofTNF-. When chal-
lenged with lipopolysaccharide, alveolar macrophages of
smoker rats released much more TNF-t but, in such a
case, TNF-t release was about one half of that observed
in the control group. Peritoneal macrophages of both
control and smoker rats were unable either to generate
high levels of superoxide anion or to release significant
amounts of TNF-. The results clearly demonstrated the
activated state of alveolar macrophages and the resting
state of peritoneal macrophages.
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Introduction
The lung represents a frequent site of inflamma-
tion because of its direct exposure to noxious
agents, antigenic materials and invasion by
microorganisms. Cigarette smoking, exposing the
surface of the lower respiratory tract to more than
4000 chemical constituents such as polynuclear
aromatic hydrocarbons and tobacco specific nitros-
amines, has been associated with inflammatory
processes.
2 The development of pulmonary in-
flammation is known to involve cellular events
controlled by a variety of cytokines. These mediate
interactions between macrophages (Mb), lympho-
cytes and granulocytes and represent an important
event in the regulation of airway inflammation. 3’4
In fact there is evidence that alveolar MqS, which
are derived from blood monocytes, may mediate
many of the harmful effects of smoking, exerting
their activity at the inflammatory sites partly
directly and partly through the action of tumour
necrosis factor (TNF) and other immunological
mediators. Moreover interactions between TNF
and other cytokines are of pivotal importance in the
mediation of the activation state of Mb.
6 TNF-o is
a protein with a wide range of biological and
inflammatory activities. The pleiotropic nature of
its action is due to the fact that TNF receptors are
present on virtually all cells examined and TNF
action leads to the activation of a large array of
cellular genes and of multiple signal transduction
pathways.
7 Moreover TNF is chemotactic for
monocytes and polymorphonuclear cells (PMN),
stimulates phagocytosis, adherence to endothelium
and superoxide anion production by these cells,
induces procoagulant activity and activates Mb
resulting in interleukin-1 and prostaglandin-E2
production. Thus, the locally regulated generation
of TNF<z at the sites of injury represents an
important autocrine-paracrine control mechanism
operative in the inflammatory response.
Despite the wide consumption of cigarettes and
the important role of alveolar Mb in the lung, little
is known about the effect of long-term exposure to
cigarette smoke, under controlled conditions,
concerning the eventual release of cytokines. In a
previous work the authors demonstrated that, after
a single episode of acute cigarette smoking, alveolar
Mb became activated and released TNF-o. The aim
of this study was to investigate the effect of chronic
smoke in the activation of alveolar Mb of rats and
in the release of cytokines such as TNF-o and
interferon (IFN). The production of superoxide
anion by alveolar Mq and the eventual variations
of enzymes such as fl-glucuronidase and lactate
dehydrogenase in both bronchoalveolar fluid (BAL)
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and peritoneal fluid (PF) were also examined.
Finally we evaluated whether the release of
cytokines after stimulation of alveolar and peri-
tonealM of smoker rats with lypopolysaccharide
would be stimulated or depressed.
Materials and Methods
Animals: Outbred Wistar male rats (Charles River)
of an initial body weight of 150 + 20 g were used
throughout the experiments. Animals were sub-
divided in two groups (control and chronic
smoker rats), kept under conventional conditions
and weighed monthly. Groups of six rats each
were lodged for 2h, daily for 4 months in a
smoke chamber as described previously,
9 during
which animals breathed air containing the smoke
of two cigarettes without filter (Camel). This
particular brand was chosen only because it is an
internationally known brand of cigarette. Immedi-
ately after the last smoking session and 8
and 24h thereafter, animals received an in-
tramuscular overdose of Nembutal (Serva) and
blood was thereafter withdrawn from the femoral
vein with an insulin-type syringe containing
10 IU/ml of heparin (Liquemin, Roche); 0.2 ml
was used for the determination of carboxy-
haemoglobin (COHb) and the remainder was
centrifuged at 800xg" for 10min. Plasma was
stored at -80C until the determination of
cytokines. Afterwards 10ml of sterile Hanks’
balanced solution at a pH of 7.4, containing
5 IU/ml heparin, were injected into the peritoneal
cavity, the abdomen was gently massaged and
about 8 1 ml were aspirated in sterile conditions
for the collection of peritoneal M present in
peritoneal fluid (PF). Bronchoalveolar lavage
(BAL) was performed in the rats through
a catheter inserted into the rat trachea with
heparinized (0.1 IU/ml) sterile Hanks’ solution.
Five washes of 5 ml each were carried out in
rapid succession and the lavage fluids were
pooled. Recovery was about 90%.
Control animals (air-sham exposed rats) were
subjected to the same procedure except that the
chamber was insufl:lated with air only.
Cell isolation and culture" The recovered BAL and PF
were centrifuged at 300 x g, for 10 min at 4C;
supernatants were collected and stored at -80C;
cells were washed twice in cold RPMI 1640 medium
(Gibco) and resuspended in a small volume of the
same medium. After counting in a Biirker chamber,
cells were diluted to the desired final concentration
(106 viable cells/ml) with LPS-free RPMI 1640
containing 10% of heat-inactivated (56C for
60 min) foetal calf serum (FCS), 2 mM L-glutamine,
100 U/ml penicillin G and 100/ig/ml streptomycin.
The sedimented cells were proved to be macro-
phages (about 80% in the smokers) by nonspecific
esterase staining. Separated Mb were tested for
viability by blue exclusion method and more than
95% were found to be viable. Macrophages were
cultured at a final volume of 0.2 ml per well in
96-well culture plates (Costar) and incubated for
24 h at 37C in a humidified atmosphere (95% air:
5% COg). This period of time was chosen after
preliminary experiments had shown that the highest
TNF-0 concentration was obtained after 24 h.
9
Plates were then centrifuged at 300 g" for 10 min
at 4C, supernatants were collected and stored at
-80C until TNF and IFN determinations. To
verify cell responsiveness other lots of Mb
suspension were challenged with 1/ig/ml bacterial
lipopolysaccharide (LPS) from Escherichia coli
(Sigma) and treated as above.
Proteins were measured directly in the wells
using the method of Lowry eta/.,
1 after two
washings with saline and dissolving sedimented
cells with 0.1 ml of 0.1 N NaOH for 12 h at room
temperature. All media used were proved negative
for endotoxin contamination by using the Limulus
amoebocyte lysate gel test. Because the exposure of
macrophages to endotoxin during the collection
procedure cannot be absolutely excluded, super-
natants of either BAL or PF were tested for
endotoxin contamination and proved to be
negative.
COHb levels: Blood COHb levels were estimated as
an indicator for the biological effects of cigarette
smoking. In order to check whether the smoke
exposure was constant for all animals, the change
of COHb in the blood of rats before and
immediately after the smoking session was
measured by a spectrophotometric method.
11
Cytokine determination: Supernatants were titrated for
antiviral activity (AA) with a microplaque reduc-
tion assay
12 using L929 murine cells and vesicular
stomatitis virus (VSV, Indiana strain) as a challenge
virus. Cell monolayers were infected with 50
plaque-forming units of VSV and all samples were
tested twice in quadruplicate. Titrations were
always performed employing the international
reference preparation for murine IFN. Titres are
reported as international units per ml (IU/ml).
TNF activity was determined by the method of
Ruff and Gifford
13 with some modifications. Briefly,
L929 cells were seeded at a density of 4 x 104 cells
per well in 96-well culture dishes in 100/il of
Eagle’s MEM to which 10% FCS and antibiotics
had been added. After 4 h of incubation at 37C in
a humidified atmosphere (95% air :5% COg), two-
fold serial dilutions of the samples in 2/lg/ml of
actinomycin D (Serva), were prepared in separate
96-well culture dishes. Then 100/zl of each dilution
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was transferred into the corresponding well and
plates, and further incubated for 18 h at 37C in the
humidified atmosphere. Supernatants were then
removed and cells stained with 0.1% crystal violet.
After drying, 100 #1 of 33% acetic acid was added
to each well to dissolve the dye. Plates were finally
read at 540 nm on a Titertek Multiskan microElisa
reader. Units of TNF activity were defined as the
reciprocal of the dilution causing 50% of maximum
cytotoxicity.
Human recombinant TNF-0 (Biogen BASF/
Knoll) with a specific activity of 1.5 x 107 units/mg
proteins was used as internal standard. TNF-o
activity was calculated as units/106 cells.
Because some subclones of L929 cells have been
shown to be sensitive to either other cytokines or
cytotoxic agents, in order to compare TNF-0
biological activity with the TNF-o antigen really
present in our samples, we performed some
determinations using both biological assay and a
commercial enzyme-linked immunosorbent assay
(TNF-ALPHA-EASIA, Medgenix Diagnostics,
Belgium), which showed no cross-reaction with
other cytokines such as IFN and interleukins.
Other chemical and enzymatic determinations: Superoxide
anion generation by alveolar Mq was measured as
the superoxide dismutase-inhibitable reduction of
ferricytochrome c in presence and absence of
zymosan.
14 Results were expressed as nM/105 cells.
Lactate dehydrogenase and fl-glucuronidase were
measured in the supernatants of BAL and PF by
colorimetric kits (Sigma) and the results were
reported as U/ml.
Statistical anasis" Evaluation of experimental data
was performed using two-tail:ed Student’s t-test
with p < 0.05 as the minimal level of significance.
Results
Body weight measured monthly during the 4
months of experiments was each time significantly
lower (p < 0.001) in the smoker group than in
air-sham exposed rats (Fig. 1).
After the last smoking session the blood COHb
concentration in smoker rats was 8.5 -t- 1.2% (Table
1). The total recovery of alveolar Mq from BAL
remained practically constant in both smoker and
control rats. In contrast, PMN in the BAL of
smoker rats significantly increased in respect to
air-sham exposed rats and, at the same time,
peritoneal Mq in the PF decreased (Table 1).
When alveolarM were collected immediately
after the last smoking session (0 h) and 8 and 24 h
thereafter and were incubated for 20 min at 37C in
presence and absence of zymosan, superoxide anion
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FIG. 1. Body weight expressed as mean ___S.D. measured monthly in both
chronic smoker (full columns) and control (empty columns) rats. The
values at 0 time represent the weight of the rats before the experiment.
*p < 0.001 in respect to control values (n 20).
control values, but remained unchanged after
incubation of peritonealM (Table 2).
Enzymatic analyses of BAL of smokers revealed
a significant increase of /-glucuronidase and a
decrease of lactate dehydrogenase, but both
remained practically unvaried in the PF (Table 3).
As the results were consistent with a state of
metabolic activation of the alveolarM population
recovered from chronic smoke-exposed rats, we
investigated whether these cells release TNF-o.
Figure 2 (bottom panel) shows that alveolar
collected from smoker rats immediately after the
last smoking session (0 h) and 8 and 24 h thereafter
and incubated for 24 h at 37C in a humidified
atmosphere, spontaneously released 77 -t- 28, 80 -t-
23 and 84-t-34 units of TNF-0 per 106 cells
respectively, these values being significantly higher
than those obtained after incubation of alveolar
collected from sham-exposed control rats. More-
over alveolar Mq obtained from BAL of both
smoker and control rats challenged with 1/,g/ml of
LPS and incubated Cas above, released much more
TNF-, but in such cases, TNF- production by
alveolarM of the smoker group was significantly
decreased to about one half of that of the control
group (Fig. 2, top panel). Immunoenzymatic deter-
minations on samples, the biological activity of
which is reported in Fig. 2, gave practically the
same TNF-0 units per 106 cells (data not shown).
Table 1. HbCO in blood and concentration of total cells col-
lected from bronchoalveolar fluid and peritoneal fluid of both
control and smoker rats
Parameter Controls Smokers
HbCO (%) -1 _+ 1.1 8.5 _+ 1.2
AlveolarM x 106) 1.45 _+ 0.5 1.67 _+ 0.41
Alveolar PMN x 105) 0.17 _+ 0.09 0.33 _+ 0.14"*
Peritoneal M x 106) 9.23 _+ 2.65 6.72 _+ 2.5*
*p < 0.05 and **p < 0.01 in respect to control values (n 8).
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Table2. Superoxide anion (nM/105 cells) produced by alveolar and peritoneal macrophages,
collected from both smoker and control rats 0, 8 and 24 h after the last smoking session
AlveolarM Peritoneal
Time after
the smoking session (h) Controls Smokers Controls Smokers
0 5.3 + 4.5 12.4 + 2* 5.3 + 2.9 6.7 + 2.4
8 4.4 + 0.8 31.8 + 12.7* 6.2 + 3.1 7.5 + 2.5
24 5.7 ___
1.6 15.2 4- 4.4* 8.2 4- 3.3 11.5 4- 3
Total mean 5.2 + 2.9 18.6 + 9.9** 6.6 + 3 8.6 + 3.2
p < 0.05 (n 6) and ** p < 0.001 (n 18) in respect to control values.
Table 3. Lactate dehydrogenase and fl-glucuronidase measured in the supernatant of bronchoalvedar fluid and peritoneal fluid,
both collected from chronic smoker and control rats 0, 8 and 24 h after the last smoker session
Supernatant bronchoalveolar fluid Supernatant peritoneal fluid
Lactate dehydrogenase fl-glucuronidase Lactate dehydrogenase fl-glucuronidase
(U/ml) (U/ml) (U/ml) (U/ml)
Time after the
smoking session (h) Controls Smokers Controls Smokers Controls Smokers Controls Smokers
0 83 -t- 14 76 4- 33 4- 0.6 2.9 4- 0.9** 93 4- 23 161 4- 106 1.8 4- 1.7 7.7 4- 3.9*
8 97 4- 8 63 4- 10" 1.4 -t- 0.3 2.6 4- 0.8* 169 4- 79 64 4- 54 4.7 4- 1.4 6.3 4- 3.7
24 72 4- 20 59 4- 13 0.7 4- 0.16 3.1 4- 0.7** 99 4- 19 39 4- 14* 2 4- 2 6.5 4- 3.8
Total mean 85 4- 17 67 4- 23* 1.1 + 0.5 2.8 + 0.8*** 118 + 56 102 + 94 2.7 + 2 7 + 3.6
*p < 0.5 (n 6), **p < 0.01 (n 6) and ***p < 0.001 (n 18), in respect to control values.
AlveolarM collected from both smoker and
control rats were unable to release any antiviral
activity and, either TNF-, or IFN were also absent
in the supernatants of BAL and PF and in plasma
(data not shown). Instead peritoneal Mq of both
smoker and control rats released, either spontan-
eously, or after LPS induction, little and extremely
variable amounts of TNF-0 and IFN (Table 4). We
attempted to correlate individual ratios of TNF-0
released by alveolar Mq compared with TNF-0
released by peritoneal Mq5 of both control and
smoker rats. As shown in Table 5 ratios obtained
from smokers were always higher than those
obtained from controls although extremely var-
iable.
Discussion
Some biological effects of chronic smoke in rats
have been evaluated. During the 4 months of the
smoking period the body-weight increments were
always lower than those of control rats. Although
the cigarette smoking effects in lowering the
body-weight are well known, 15’16 little attention has
been devoted to studying the effect of chronic
smoke on the metabolic rate in rats where
sympathoadrenal activation by nicotine appears to
be primarily responsible for the metabolic eects of
smoking.
17
Smoking rats were lodged in the smoking
chamber daily for 2 h, during which time they
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breathed the smoke of two cigarettes. Evaluation
of COHb blood levels, immediately after the last
smoking session, gave values of about 8.5% which
compared well with those observed in guinea pig
and in human cigarette smokers. 18J9 The total
number of alveolar M4 collected from BAL of
chronic smoker rats was unchanged compared with
that of control rats or acute smoker rats, but PMN
increased significantly in the BAL of smoker rats.
Previous work by Costabel and Guzman2 and
others2’2’22 clearly shows a constant increase of
PMN in the BAL after smoking, probably due to
the action of chemotactic factors23’24 produced by
both alveolar and pulmonary cells.
The major aim of the investigation reported here
was to determine whether resident alveolar Mq of
chronic smoker rats produced TNF-0. The present
results clearly demonstrated that alveolar Mq5
collected immediately after (0 h) and 8 and 24 h
following the last smoking session and incubated
for 24 h at 37C spontaneously released significant
and constant amounts ofTNF-0. Immunoenzymatic
analyses on these samples gave about the same
values, thus assuring the identity of the cytokine.
We are unable to assess which substance stimulated
the release of TNF-0 and at least IFN-
25 can be
excluded, because we were unable to detect any
antiviral activity in our samples. TNF-z and IFN
were also absent in the supernatants of BAle and
PL, but this is probably due to the dilution and



























FIG. 2. TNF-a units, expressed as mean ___S.D. released either spon-
taneously (bottom), or after induction with LPS (top) by alveolar M
collected from both chronic smoker (hatched columns) and control
(empty columns) rats 0, 8 and 24 h after the last smoking session.
*p < 0.01 and **p < 0.001 in respect to control values (n 6).
Moreover the absence ofTNF-0 in the plasma could
be due to either cytokine inactivation during the
transalveolar passage or the dilution in body fluids
and the rapid clearance from plasma.26’2v
Alveolar Mq collected from both control and
smoker rats were extremely sensitive to low LPS
concentrations but, in the last case, TNF-0 release
Table 5. Individual ratios expressed as mean _+ S.D. of
TNF- obtained from alveolar vs. peritoneal macro-
phages in both control and smoker rats 0, 8 and 24 h
after the last smoking session
Ratios
Time after the last
smoking session (h) Controls Smokers
0 0.6 -4- 0.3 20.2 -t- 35.5
8 1.2 + 0.3 4.6 + 1.5
24 5.7 + 3.1 76 + 46
was about one-half of that observed in the control
group, in agreement with results of others obtained
in the mouse.
28 Peritoneal Mq of the control and
smoker group, which represent a resident popula-
tion without any direct contact with air pollutants
and smoke products, released small amounts of
TNF-o and IFN either spontaneously or after
challenge with LPS. This is also clarified by the
analysis of individual ratios of alveolar TNF-cz
versus peritoneal TNF-o released various time after
the last smoking session evaluated in both control
and smoker rats. The high variability of the ratios
is probably due to the scarce sensitivity of our
bioassay especially when the units of TNF-o were
below 5. Taken together, the results suggest that
peritoneal Mq were in a resting state and alveolar
Mq were primed, based on the fact that only primed
Mq are able to release massive amounts of TNF-o
after stimulation with LPS.29’3 Moreover it is
known
29 that at least two pathways govern the
release of TNF-, one is LPS specific and the other
phagocytic trigger specific, suggesting that the
priming effect for the TNF-o release is variable and
probably related to a particular triggering stimulus.
The activated state of alveolar Mq5 of chronic
smoker rats, due to either smoke products and
pollutants,31’2 or a self-priming effect ofTNF->-s
is also suggested by the significant increase of
superoxide anion generation and of fl-glucur-
onidase. At the same time lactate dehydrogenase in
the BAL of smoker rats, which represents a
cytoplasmic marker employed as a measure of the
cell lysis, remained unchanged or only slightly
Table 4. TNF- and IFN (IU/106 cells) expressed as mean _+ S.D. produced by peritoneal macrophages collected from both chronic
smoker and control rats 0, 8 and 24 h after the last smoking session and incubated for 24 h at 37C
Peritoneal macrophages
Controls Controls_+ LPS Smokers Smokers ___
LPS
Time after
the smoking session (h) TNF IFN TNF IFN TNF IFN TNF IFN
0 30 + 11 7.4 -+ 8.5 36 + 12 11 _+ 9 12 _+ 7 19 _+ 17 20 _+ 6 20 _+ 18
8 29 +_ 6 2.6 _+ 5.8 49 _+ 6 8_+8 19 _+ 10 15 _+ 11 35 _+ 30 16 _+ 10
24 25_+18 26_+29 25-+18 29-+25 2-t-4 -+2 7_+3 2-+4
Total mean 23 _+ 13 11 _+ 18 37 ___
15 16 _+ 17 10 _+ 9 11 _+ 14 20 _+ 18 13 _+ 15
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decreased compared with the control group. This
suggests that the increase of the fl-glucuronidase in
the BAL was not due to a lytic effect on the cells,
but to a secretagogue effect on alveolar Mb and
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